The company attributed the drop in medical device sales to deferral of medical procedures during the pandemic, hitting its surgery, orthopedics and vision business. However, the full-year report shows market recovery during the second half of last year.
Six things to know about orthopedics sales:
1. Johnson & Johnson’s medical devices segment sales dropped 11 percent in 2020, hitting nearly $23 billion.
2. Orthopedic sales dropped just 3.7 percent year over year in the fourth quarter of 2020.
3. Hip sales were down 11 percent overall, hitting $1.2 billion. In the U.S., hip sales declined 8.2 percent to $793 million.
4. Knee sales dropped 21 percent in 2020, hitting $1.1 billion. In the U.S., knee sales were down 16.4 percent to $743 million.
5. Trauma sales declined 3.9 percent to $2.6 billion overall. In the U.S., trauma sales were relatively flat year over year while trauma sales dropped 9.6 percent internationally.
6. Johnson & Johnson’s spine and sports segment sales dropped 15.7 percent overall in 2020, hitting $2.6 billion. U.S. spine and sports sales were down 16.7 percent last year, hitting $1.6 billion.
More article on orthopedics:
Orthopedic implant market to hit $8.97B by 2025
1st AR knee replacement performed in US by HSS surgeon
50 things to know about 10 of the biggest orthopedic device companies
